Antipsychotics-induced tardive syndrome: A retrospective epidemiological study

Clinical Neuropharmacology

Volumn 37, Issue 4, 2014, Pages 111-115

  Lee, Min Jing ^a   Lin, Pao Yen ^a,b   Chang, Yung Yee ^a   Chong, Mian Yoon ^a   Lee, Yu ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

antipsychotics; tardive dyskinesia; tardive syndrome

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; CHLORPROMAZINE; CLOZAPINE; FLUPENTIXOL; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PALIPERIDONE; QUETIAPINE; RISPERIDONE; SULPIRIDE; ZIPRASIDONE;

ADULT; AKATHISIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DELUSIONAL DISORDER; DRUG INDUCED DISEASE; DYSTONIA; EXTRAPYRAMIDAL SYNDROME; FEMALE; HEALTH SURVEY; HUMAN; MALE; MEDICAL RECORD REVIEW; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCHIZOPHRENIA; SYNDROME; TARDIVE DYSKINESIA; TARDIVE SYNDROME; TREMOR; AGED; MENTAL DISORDERS; MIDDLE AGED; MOVEMENT DISORDERS; PSYCHOLOGICAL RATING SCALE;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; MOVEMENT DISORDERS; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84922207883     PISSN: 03625664     EISSN: 1537162X     Source Type: Journal    
DOI: 10.1097/WNF.0000000000000040     Document Type: Article

References (32)

1. Go CL, Rosales RL, Caraos RJ, et al. The current prevalence and factors associated with tardive dyskinesia among Filipino schizophrenic patients. Parkinsonism Relat Disord 2009;15:655-659
2. Fernandez HH, Friedman JH. Classification and treatment of tardive syndromes. Neurologist 2003;9:16-27
3. Lerner V, Miodownik C. Motor symptoms of schizophrenia: is tardive dyskinesia a symptom or side effect? A modern treatment. Curr Psychiatry Rep 2011;13:295-304
4. Seeman P. Dopamine D2 receptors as treatment targets in schizophrenia. Clin Schizoph Related Psychos 2010;4:56-73
5. Kulkarni SK, Naidu PS. Pathophysiology and drug therapy of tardive dyskinesia: current concepts and future perspectives. Drugs Today (Barc) 2003;39:19-49
6. Tarsy D, Baldessarini RJ Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics? Mov Disord 2006;21:589-598
7. Woods S, Morgenstern H, Saksa J, et al. Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study. J Clin Psychiatry 2010;71:463-474
8. Smith JM, Baldessarini RJ. Changes in prevalence, severity, and recovery in tardive dyskinesia with age. Arch Gen Psychiatry 1980;37:1368-73
9. Revuelta GJ, Cloud L, Aia PG, et al. Tardive dyskinesias. In: Albanese A, Jankovic J, eds. Hyperkinetic Movement Disorders, Blackwell Publishing, Ltd, 2012: 331-352
10. Lin HN, Chen CY. Tardive dyskinesia in patients treated with antipsychotics in chronic wards in Taipei. Taiwan Yi Xue Hui Za Zhi 1980; 79:332-337
11. Ko GN, Zhang LD, YanWW, et al. The Shanghai 800: prevalence of tardive dyskinesia in a Chinese psychiatric hospital. Am J Psychiatry 1989;146: 387-389
12. Lo T, Kwok I, Cheung TK, et al. Tardive dyskinesia. J Hong Kong Psychiatr Assoc 1983;3:18-25
13. Burke RE, Fahn S, Jankovic J, et al. Tardive dystonia: late-onset and persistent dystonia caused by antipsychotic drugs. Neurology 1982;32: 1335-1346
14. Bhidayasiri R, Boonyawairoj S. Spectrum of tardive syndromes: clinical recognition and management. Postgrad Med J 2011;87:132-141
15. Marsalek M. Tardive drug-induced extrapyramidal syndromes. Pharmacopsychiatry 2000;33(suppl 1): 14-33
16. Kiriakakis V, Bhatia KP, Quinn NP, et al. The natural history of tardive dystonia. A long-term follow-up study of 107 cases. Brain 1998;121 (Pt 11):2053-2066
17. Casey DE. Effects of clozapine therapy in schizophrenic individuals at risk for tardive dyskinesia. J Clin Psychiatry 1998;3(suppl 3): 31-37
18. Fahn S, Jankovic J. The tardive syndromes: phenomenology, concepts on pathophysiology and treatment, and other neuroleptic-induced syndromes. In: Fahn S, Jankovic J, eds. Principles and Practice ofMovementDisorders, Philadelphia, pa: Churchill Livingstone, 2007: 479-518
19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. American Psychiatric Association; 2000
20. Chouinard G, Margolese HC. Manual for the Extrapyramidal Symptom Rating Scale (ESRS). Schizophr Res 2005;76:247-265
21. Pandurangi AK, Aderibigbe YA. Tardive dyskinesia in non-western countries: a review. Eur Arch Psychiatry Clin Neurosci 1995;246:47-52
22. Lee Y, Lin PY, Chang YY, et al. Antidepressant-induced tardive syndrome: a retrospective epidemiological study. Pharmacopsychiatry 2013;46: 281-285
23. van Harten PN, Hoek HW, Matroos GE, et al. Incidence of tardive dyskinesia and tardive dystonia in African Caribbean patients on long-term antipsychotic treatment: the Curaçao extrapyramidal syndromes study V. J Clin Psychiatry 2006;67:1920-1927
24. Sethi KD, HessDC, Harp RJ. Prevalence of dystonia in veterans on chronic antipsychotic therapy. Mov Disord 1990;5:319-321
25. Adityanjee , Aderibigbe YA, Jampala VC, et al. The current status of tardive dystonia. Biol Psychiatry 1999;45:715-730
26. van Harten PN, Kahn RS. Tardive dystonia. Schizophr Bull 1999;25:741-748
27. Van Putten T. The many faces of akathisia. Compr Psychiatry 1975;16: 43-47
28. Barnes TR, Braude WM. Akathisia variants and tardive dyskinesia. Arch Gen Psychiatry 1985;42:874-878
29. Stacy M, Jankovic J. Tardive tremor. Mov Disord 1992;7:53-57
30. Solbrig MV, Koob GF, Fallon JH, et al. Tardive dyskinetic syndrome in rats infected with Borna disease virus. Neurobiol Dis 1994;1:111-119
31. Chouinard G, Annable L, Mercier P, et al. A five year follow-up study of tardive dyskinesia. Psychopharmacol Bull 1986;22:259-263
32. Murray RM, Van Os J. Predictors of outcome in schizophrenia. J Clin Psychopharmacol 1998;18:2s-4s